DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Scheen AJ.
DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: From rationale to clinical aspects.
Expert Opin Drug Metab Toxicol 2016;
12: 1407-1417
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.